Choice Aims To Move Hormone-Free Contraceptive Implant Into Clinical Trials By 2028
Choice Prioritizes Female Sterilization Approval By 2030 Followed By General Contraception And Motorized Version
The implant is designed as a lifetime device with minimal wear and tear due to infrequent valve activation. Picture Courtesy: Choice 
